No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 1.7x · 10Y median 4.8x · 12th percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 23
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T17:52:17.175Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Lucyd, Inc (LUCY) stock was $0.93 as of Oct 6, 2026, 1:44 PM EDT, up 4.37% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -55.1% · 3-year avg -54.8%/yr
Lucyd, Inc develops and sells smart eyewear in North America. It offers smart eyewear products to enable wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform smartphone tasks hands-free, as well as prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sport glasses under the Lucyd Lyte, Lucyd Armor, Nautica, Eddie Bauer, and Reebok brand names.
Medical - Instruments & Supplies · North Miami, FL
Next Earnings Date
Nov 12, 2026
37 days away
EPS Estimate
-0.35
Revenue Est.
$2.00M
Last Quarter Results
EPS
$-0.26
vs Estimate
$-0.37
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1LUCY | $5.85M | $0.93 | +4.37% | -55.10% | N/A | N/A | N/A |
| 2ENLV | $5.81M | $0.35 | -4.64% | -97.68% | -69.81% | -54.76% | vs LUCY |
| 3SNOA | $5.79M | $1.21 | -0.82% | -69.25% | -59.29% | -47.31% | vs LUCY |
| 4CUPR | $5.74M | $2.14 | -4.89% | -74.72% | N/A | N/A | vs LUCY |
| 5CDIO | $6.01M | $2.03 | -1.46% | -54.55% | N/A | N/A | vs LUCY |
| 6SCNX | $5.69M | $3.50 | -5.66% | -82.72% | N/A | N/A | vs LUCY |
N/A
$1.01M
vs Estimate
$900000.00
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$0.93
High
N/A
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-0.35 | $-0.35 | $-0.35 | 1 |
| Quarter ending Dec 2026 | $-0.13 | $-0.13 | $-0.13 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-1.23 | $-1.23 | $-1.23 | 1 |
| FY 2027 | $-0.42 | $-0.42 | $-0.42 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $2.00M | $2.00M | $2.00M | 1 |
| Quarter ending Dec 2026 | $3.50M | $3.50M | $3.50M | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $7.20M | $7.20M | $7.20M | 1 |
| FY 2027 |
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| $22.00M |
| $22.00M |
| $22.00M |
| 1 |
